Kidney-Protector Lipidic Cilastatin Derivatives as Structure-Directing Agents for the Synthesis of Mesoporous Silica Nanoparticles for Drug Delivery

Kidney-Protector Lipidic Cilastatin Derivatives as Structure-Directing Agents for the Synthesis of Mesoporous Silica Nanoparticles for Drug Delivery

Mesoporous silica nanomaterials have emerged as promising vehicles in controlled drug delivery systems due to their ability to selectively transport, protect, and release pharmaceuticals in a controlled and sustained manner. One drawback of these drug delivery systems is their preparation procedure...

Full description

Bibliographic Details
Main Authors: Samuel Martinez-Erro, Francisco Navas, Eva Romaní-Cubells, Paloma Fernández-García, Victoria Morales, Raul Sanz, Rafael A. García-Muñoz
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
mesoporous silica nanoparticles (MSNs)
drug-structure-directing agent (DSDA)
cilastatin
drug delivery systems
sustained and controlled release
Online Access:https://www.mdpi.com/1422-0067/22/15/7968

Internet

https://www.mdpi.com/1422-0067/22/15/7968

Similar Items